Results 301 to 310 of about 6,889,134 (415)

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Mechanical and biological properties of 3D printed bone tissue engineering scaffolds. [PDF]

Front Bioeng Biotechnol
Wang M, Xu Y, Cao L, Xiong L, Shang D, Cong Y, Zhao D, Wei X, Li J, Fu D, Lian H, Zhao Z.   +11 more
europepmc   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Biomimetic structural design in 3D-printed scaffolds for bone tissue engineering. [PDF]

Mater Today Bio
Huang D, Li Z, Li G, Zhou F, Wang G, Ren X, Su J.   +6 more
europepmc   +1 more source

TISSUE ENGINEERING, STEM CELLS AND CLONING: APPLICATIONS IN UROLOGY

, 2001
Anthony Atala
openalex   +2 more sources

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Application of Light-Responsive Nanomaterials in Bone Tissue Engineering. [PDF]

Pharmaceutics
Liu A, Wang C, Deng S, Zhang S, Zhao Z, Xiao H, Ying T, Yi C, Li D.   +8 more
europepmc   +1 more source

CARDIOVASCULAR TISSUE ENGINEERING - VASCULAR COMPOSITE GRAFT BASED ON A MACROPOROUS MESH

, 2001
Stefan Jockenhoevel, Khaled Chalabi, Anna B. Roehl, Jörg S. Sachweh, Bruno J. Messmer   +4 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Three-Dimensional Bioprinting for Retinal Tissue Engineering. [PDF]

Biomimetics (Basel)
Wu KY, Osman R, Kearn N, Kalevar A.
europepmc   +1 more source